The Penicillins and Streptomycins dosage market in Peru showed considerable fluctuations over the years. The market size in 2023 was valued at $80.808 million USD. Despite encountering declines in 2017 and 2022, the market showed resilience with a slight increase in 2023. The five-year compound annual growth rate (CAGR) ending in 2023 was 2.15%, indicating modest growth.
Future trends to watch for include potential market stabilization post-pandemic, increased healthcare investment, and shifts towards antimicrobial resistance solutions which could drive innovation and demand in the antibiotics sector, impacting both market size and growth prospects.
How does Peru rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 13 | 13 Belgium | 129,530,000 | 2023 | +1.01% | +0.63% | View data |
| 14 | 14 Thailand | 89,928,000 | 2023 | +4.19% | +3.03% | View data |
| 15 | 15 Peru | 80,808,000 | 2023 | +1.93% | +2.15% | |
| 16 | 16 Chile | 68,962,000 | 2023 | +0.58% | +0.71% | View data |
| 17 | 17 Malaysia | 62,268,000 | 2023 | +7.35% | +7.89% | View data |
